These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23970747)

  • 1. Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy.
    Page ID; McKew SJ; Kudzala AG; Fullwood C; van Oosterhout JJ; Bates I
    Int J STD AIDS; 2013 Jun; 24(6):449-53. PubMed ID: 23970747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-associated anaemia before and after initiation of antiretroviral therapy at Art Centre of Minilik II Hospital, Addis Ababa, Ethiopia.
    Adane A; Desta K; Bezabih A; Gashaye A; Kassa D
    Ethiop Med J; 2012 Jan; 50(1):13-21. PubMed ID: 22519158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the need for antiretroviral treatment and an assessment of a simplified HIV/AIDS case definition in rural Malawi.
    McGrath N; Kranzer K; Saul J; Crampin AC; Malema S; Kachiwanda L; Zaba B; Jahn A; Fine PE; Glynn JR
    AIDS; 2007 Nov; 21 Suppl 6(Suppl 6):S105-13. PubMed ID: 18032933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial.
    Venter WDF; Majam M; Akpomiemie G; Arulappan N; Moorhouse M; Mashabane N; Chersich MF
    BMC Public Health; 2017 Jul; 17(Suppl 3):445. PubMed ID: 28832288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with timely initiation of antiretroviral therapy in two HIV clinics in Lilongwe, Malawi.
    Johnson DC; Feldacker C; Tweya H; Phiri S; Hosseinipour MC
    Int J STD AIDS; 2013 Jan; 24(1):42-9. PubMed ID: 23467293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.
    Owiredu WK; Quaye L; Amidu N; Addai-Mensah O
    Afr Health Sci; 2011 Mar; 11(1):2-15. PubMed ID: 21572851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting.
    Obirikorang C; Yeboah FA
    J Biomed Sci; 2009 Nov; 16(1):102. PubMed ID: 19922646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
    Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
    Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.
    Ngongondo M; Rosenberg NE; Stanley CC; Lim R; Ongubo D; Broadhurst R; Speight C; Flick R; Tembo P; Hosseinpour MC
    BMC Infect Dis; 2018 Jan; 18(1):39. PubMed ID: 29334932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A targeted approach for routine viral load monitoring in Malawian adults on antiretroviral therapy.
    Mungwira RG; Divala TH; Nyirenda OM; Kanjala M; Muwalo F; Mkandawire FA; Choko A; Taylor TE; Mallewa J; van Oosterhout JJ; Laufer MK; Laurens MB
    Trop Med Int Health; 2018 May; 23(5):526-532. PubMed ID: 29505108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
    Mildvan D; Creagh T; Leitz G;
    Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS.
    Renner LA; Dicko F; Kouéta F; Malateste K; Gueye RD; Aka E; Eboua TK; Azondékon A; Okomo U; Touré P; Ekouévi D; Leroy V;
    J Int AIDS Soc; 2013 Sep; 16(1):18024. PubMed ID: 24047928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of affordable screening markers to detect CD4+ T-cell counts below 200 cells/mul among HIV-1-infected Ugandan adults.
    Miiro G; Nakubulwa S; Watera C; Munderi P; Floyd S; Grosskurth H
    Trop Med Int Health; 2010 Apr; 15(4):396-404. PubMed ID: 20180936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 testing at clinics to assess eligibility for antiretroviral therapy.
    Lumala R; van den Akker T; Metcalf CA; Diggle E; Zamadenga B; Mbewa K; Akkeson A
    Malawi Med J; 2012 Jun; 24(2):25-8. PubMed ID: 23638266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of total lymphocyte count to predict absolute CD4 count in HIV-seropositive cases.
    Gautam H; Saini S; Bhalla P; Singh T
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(5):292-5. PubMed ID: 20923954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between clinical and immunological ART eligibility criteria for children in Malawi.
    O'Hare B; Milner DA; Newberry L; Pelani I; Malisita K
    BMC Res Notes; 2014 Sep; 7():666. PubMed ID: 25245481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
    Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
    Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
    PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.